Nucleos(t)ide Analog Treatment Discontinuation in Chronic Hepatitis B Virus Infection: A Systematic Literature Review

Nucleos(t)ide Analog Treatment Discontinuation in Chronic Hepatitis B Virus Infection: A Systematic Literature Review

Background and Aims: The aim of this systematic literature review (SLR) was to examine outcomes and associated predictors following nucleos(t)ide analog (NA) treatment cessation in adult patients with chronic hepatitis B virus infection. Methods: The SLR was conducted according to PRISMA methodology...

Full description

Saved in:

Bibliographic Details
Main Authors:	Robert Gish, Kosh Agarwal, Anadi Mahajan, Supriya Desai, Saifuddin Kharawala, Rob Elston, Joyeta Das, Stuart Kendrick, Vera Gielen
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	Gastro Hep Advances
Subjects:	Antiviral Treatment Evidence-Based Care Viral Hepatitis B.
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772572324001304
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effect of potent nucleos(t)ide analog on alpha fetoprotein changes and occurrence of hepatocellular carcinoma in patients with chronic hepatitis B
by: Qianqian Ma, et al.
Published: (2025-02-01)

Application of dicarbamin in treatment of patients by a chronic hepatitis C
by: D. Yu. Konstantinov, et al.
Published: (2011-09-01)

Advances and Challenges in Antiviral Development for Respiratory Viruses
by: Luis Adrián De Jesús-González, et al.
Published: (2024-12-01)

Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV)Research in context
by: Podjanee Jittamala, et al.
Published: (2025-02-01)

In vitro study on the inhibitory effect of various essential oils against murine coronavirus mouse hepatitis virus A-59 replication
by: Karelle Contant, et al.
Published: (2025-02-01)

Advances in antiviral strategies targeting mosquito-borne viruses: cellular, viral, and immune-related approaches
by: Ayyaz Khan, et al.
Published: (2025-02-01)

Virally-initiated pain states: phenotypes, mechanisms, and future directions
by: Sara A. Dochnal, et al.
Published: (2025-01-01)

Efficacy and safety of SHEN26, a novel oral small molecular RdRp inhibitor for COVID-19 treatment: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trial
by: Jiangtao Bai, et al.
Published: (2025-01-01)

48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse
by: Wen-xiong Xu, et al.
Published: (2018-01-01)

Comment on “48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse”
by: Yafei Guo, et al.
Published: (2019-01-01)

Predictive factors associated with short‐term mortality in cats with feline infectious peritonitis treated with remdesivir or GS‐441524 or both
by: Sho Goto, et al.
Published: (2025-01-01)

An extension of the Beretta-Kuang model of viral diseases
by: Ivo Siekmann, et al.
Published: (2008-05-01)

Differences in influenza testing and treatment in micropolitan versus metropolitan areas in the U.S. using medicare claims data from 2010 to 2016
by: Alexia Couture, et al.
Published: (2025-01-01)

Prevalence of feline viral leukemia in Moscow and the Moscow Oblast with the analysis of hematological and biochemical blood parameters
by: A. P. Zenchenkova
Published: (2021-07-01)

Product videos “gone viral”
by: Lené Ehlers, et al.
Published: (2022-06-01)

NS5A replication complex inhibitor daclatasvir in the basis of chronic hepatitis C interferon-free therapy
by: M. V. Mayevskaya, et al.
Published: (2015-12-01)

AVP-GPT2: A Transformer-Powered Platform for De Novo Generation, Screening, and Explanation of Antiviral Peptides
by: Huajian Zhao, et al.
Published: (2024-12-01)

The prognostic value of ferritinemia level in patients with chronic hepatitis C
by: N. C. Sargsyants, et al.
Published: (2013-07-01)

Potentials of antiviral therapy at patients with liver cirrhosis in an outcome of HCV-infection
by: E. N. Bessonova
Published: (2011-06-01)

Synthesis of some benzimidazole derivatives endowed with 1,2,3-triazole as potential inhibitors of hepatitis C virus
by: Youssif Bahaa G. M., et al.
Published: (2016-06-01)

‘The Apex of Hipster XML GeekDOM’
by: Lynne Siemens, et al.
Published: (2011-06-01)

UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
by: José Luis Piñana, et al.
Published: (2024-08-01)

An Exhaled Breath Sampler Based on Condensational Growth and Cyclone Centrifugation (BSCC)
by: Lebing Wang, et al.
Published: (2022-04-01)

Airborne Transmission of the SARS-CoV-2 Delta Variant and the SARS-CoV-2 Omicron Variant
by: Byung Uk Lee
Published: (2021-12-01)

Navigating healthcare pathways: Cascade of prevention and care for chronic viral hepatitis in asylum seekers and refugees. A multicenter analysis in Northern Italy
by: Beatrice Formenti, et al.
Published: (2025-01-01)

A multiplex method for rapidly identifying viral protease inhibitors
by: Seo Jung Hong, et al.
Published: (2025-01-01)

B-cell non-Hodgkin's lymphoma in the patient with chronic hepatitis C and mixed cryoglobulinemia
by: V. S. Adonyeva, et al.
Published: (2015-03-01)

Formulation and optimization of polymeric nanoparticles loaded with riolozatrione: a promising nanoformulation with potential antiherpetic activity
by: Solís-Cruz Guadalupe Y., et al.
Published: (2023-09-01)

Enhanced biocidal efficacy of alcohol based disinfectants with salt additives
by: Euna Oh, et al.
Published: (2025-01-01)

Antiviral and anti-inflammatory activities of favipiravir and quinine sulfate against dengue virus serotype 1 in vitro
by: Regita Aulia Rosalina, et al.
Published: (2025-03-01)

Anti-HSV-1 agents: an update
by: Wenwen Lv, et al.
Published: (2025-01-01)

Purine but Not Pyrimidine De Novo Nucleotide Biosynthesis Inhibitors Strongly Enhance the Antiviral Effect of Corresponding Nucleobases Against Dengue Virus
by: Laurent F. Bonnac, et al.
Published: (2025-01-01)

In Vivo and In Vitro Studies Assessing the Antiviral Efficacy of Double Combinations Against Coxsackievirus B Infection
by: Adelina Stoyanova, et al.
Published: (2025-01-01)

Overview of Recent Advances in Canine Parvovirus Research: Current Status and Future Perspectives
by: Hongzhuan Zhou, et al.
Published: (2024-12-01)

A note on the use of optimal control on a discrete time model of influenza dynamics
by: Paula A. González-Parra, et al.
Published: (2010-12-01)

Future destinations: how people cured of hepatitis C using direct acting antiviral drugs progress in a new HCV-free world. A thematic analysis
by: Sarah R. Donaldson, et al.
Published: (2025-01-01)

Impact of antiviral prophylaxis on EBV viremia and posttransplant lymphoproliferative disorders in solid organ transplant recipients: a systematic review and meta-analysis
by: Marjan Moghadamnia, et al.
Published: (2025-01-01)

Isolation, genetic, and biological characterization of human adenovirus type 55 positive isolates from Wuhan, China
by: Jing Xie, et al.
Published: (2025-02-01)

BVDV comprehensive studies and species identification in high-yielding livestock populations in the Sverdlovsk Oblast
by: N. A. Bezborodova, et al.
Published: (2024-12-01)

Impact of Point-of-Care Testing on Diagnosis, Treatment, and Surveillance of Vaccine-Preventable Viral Infections
by: Kirthika Lakshmanan, et al.
Published: (2025-01-01)